The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...
However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...
Dr. Jacques Chaoulli (pronounced "shao-lee") is a wiry French Canadian physician of 53 who has almost single-handedly poked a huge hole in Canada's vaunted government health-care system. Several years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback